Related Experiment Video
Updated: Oct 3, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
3D Echo Characterization of Proportionate and Disproportionate Functional Mitral Regurgitation before and after
Sara Cimino1, Luciano Agati1, Domenico Filomena1
1Department of Clinical, Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Policlinico Umberto I, 00161 Rome, Italy.
Background:
The impact of percutaneous mitral valve repair (PMVr) on long-term prognosis in patients with functional mitral regurgitation (FMR) is still unclear. Recently, a new conceptual framework classifying FMR as proportionate (P-MR) and disproportionate (D-MR) was proposed, according to the effective regurgitant orifice area/left ventricular end-diastolic volume (EROA/LVEDV) ratio. The aim was to assess its possible influence on PMVr efficacy.
Methods:
A total of 56 patients were enrolled. MV annulus, LV volumes and function were assessed. Global longitudinal strain (GLS) was also calculated. Patients were divided into two groups, according to the EROA/LVEDV ratio. Echocardiographic follow-up was performed after 6 months, and adverse events were collected after 12 months.
Results:
D-MR patients (n = 28, 50%) had a significantly more elliptical MV annulus (p = 0.048), lower tenting volume (p = 0.01), higher LV ejection fraction (LVEF: 32 ± 7 vs. 26 ± 5%, p = 0.003), lower LVEDV, LV end-systolic volume (LVESV) and mass (LVEDV/i: 80 ± 20 vs. 126 ± 27 mL, p = 0.001; LVESV/i: 60 ± 20 vs. 94 ± 23 mL, p < 0.001; LV mass: 249 ± 63 vs. 301 ± 69 gr, p = 0.035). GLS was more impaired in P-MR (p = 0.048). After 6 months, P-MR patients showed a higher rate of MR recurrence. After 12 months, the rate of CV death and rehospitalization due to HF was significantly higher in P-MR patients (46% vs. 7%, p < 0.001). P-MR status was strongly associated with CV death/rehospitalization (HR = 3.4, CI 95% = 1.3-8.6, p = 0.009).
Conclusions:
Patients with P-MR seem to have worse outcomes after PVMr than D-MR patients. Our study confirms the importance of the EROA/LVEDV ratio in defining different subsets of FMR based on the anatomical characteristic of MV and LV.
Insights
Patients with proportionate mitral regurgitation (P-MR) face worse outcomes after percutaneous mitral valve repair (PMVr) compared to disproportionate mitral regurgitation (D-MR) patients. The effective regurgitant orifice area/left ventricular end-diastolic volume (EROA/LVEDV) ratio is crucial for stratifying functional mitral regurgitation (FMR) risk.
Area of Science:
- Cardiology
- Cardiac Surgery
- Echocardiography
Background:
- Long-term prognosis after percutaneous mitral valve repair (PMVr) for functional mitral regurgitation (FMR) remains uncertain.
- A new classification divides FMR into proportionate (P-MR) and disproportionate (D-MR) based on the EROA/LVEDV ratio.
- This study investigates the influence of this classification on PMVr efficacy.
Purpose of the Study:
- To evaluate the impact of the P-MR/D-MR classification on the outcomes of PMVr.
- To assess the prognostic value of the EROA/LVEDV ratio in FMR patients undergoing PMVr.
Main Methods:
- Fifty-six patients with FMR undergoing PMVr were analyzed.
- Patients were categorized into P-MR and D-MR groups based on the EROA/LVEDV ratio.
- Echocardiographic parameters (including GLS) and clinical adverse events (CV death, HF rehospitalization) were assessed at 6 and 12 months.
Main Results:
- D-MR patients exhibited distinct anatomical characteristics, including a more elliptical mitral valve annulus and preserved LV ejection fraction.
- P-MR patients demonstrated a higher rate of MR recurrence at 6 months.
- At 12 months, P-MR patients had significantly higher rates of cardiovascular death and heart failure rehospitalization (46% vs. 7%).
Conclusions:
- Patients with P-MR experience significantly worse clinical outcomes following PMVr compared to D-MR patients.
- The EROA/LVEDV ratio effectively stratifies FMR patients into prognostically distinct subgroups.
- This classification aids in understanding mitral valve and left ventricular anatomical differences influencing PMVr success.
More Related Videos
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse I: Introduction

